Intellectual property and COVID-19 medicines: Why a WTO waiver may not be enough

Intellectual property and COVID-19 medicines: Why a WTO waiver may not be enough

The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible t...
read more